ARAIX
Price
$77.63
Change
-$0.72 (-0.92%)
Updated
Feb 3 closing price
Net Assets
2.73B
JVMRX
Price
$28.89
Change
-$0.82 (-2.76%)
Updated
Feb 3 closing price
Net Assets
24.73B
Interact to see
Advertisement

ARAIX vs JVMRX

Header iconARAIX vs JVMRX Comparison
Open Charts ARAIX vs JVMRXBanner chart's image
Ariel Fund Institutional
Price$77.63
Change-$0.72 (-0.92%)
VolumeN/A
Net Assets2.73B
JHancock Disciplined Value Mid Cap R6
Price$28.89
Change-$0.82 (-2.76%)
VolumeN/A
Net Assets24.73B
ARAIX vs JVMRX Comparison Chart in %
View a ticker or compare two or three
VS
ARAIX vs. JVMRX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAIX is a Hold and JVMRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 24.7B vs. ARAIX (2.73B). JVMRX pays higher dividends than ARAIX: JVMRX (0.82) vs ARAIX (0.11). ARAIX was incepted earlier than JVMRX: ARAIX (14 years) vs JVMRX (14 years). JVMRX (0.75) is less costly to investors than ARAIX (0.69). JVMRX is a more actively managed with annual turnover of: 49.00 vs. ARAIX (17.00). ARAIX (1000000) and JVMRX (1000000) have matching initial minimum investment requirements. ARAIX annual gain was more profitable for investors over the last year : 6.50 vs. JVMRX (5.07). JVMRX return over 5 years is better than : 23.56 vs. ARAIX (9.54).
ARAIXJVMRXARAIX / JVMRX
Total Expense Ratio0.690.7493%
Annual Report Gross Expense Ratio0.690.7592%
Fund Existence14 years14 years-
Gain YTD6.2485.208120%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.73B24.7B11%
Annual Yield % from dividends0.110.8214%
Returns for 1 year6.505.07128%
Returns for 3 years9.0812.0775%
Returns for 5 years9.5423.5640%
Returns for 10 years62.3580.0378%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX51.170.44
+0.87%
Eventide Healthcare & Life Sciences N
FGETX25.40N/A
N/A
Fidelity Advisor Glbl Capital Apprec M
JMCCX58.29-0.09
-0.15%
JPMorgan Mid Cap Equity C
AQGIX12.48-0.07
-0.56%
AQR Global Equity I
MSHNX12.87-0.28
-2.13%
Morgan Stanley Inst Permanence A